Breakdown | |||||
TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
55.35B | 55.53B | 52.61B | 50.84B | 48.21B | 49.50B | Gross Profit |
16.09B | 15.43B | 15.40B | 14.12B | 14.19B | 13.64B | EBIT |
1.45B | 1.31B | 1.30B | 350.72M | 1.23B | 1.62B | EBITDA |
3.04B | 3.06B | 3.70B | 2.11B | 2.97B | 3.38B | Net Income Common Stockholders |
1.51B | 510.81M | 1.07B | 9.90M | 741.10M | 1.22B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
12.75B | 13.93B | 12.34B | 12.21B | 13.53B | 12.73B | Total Assets |
51.89B | 59.05B | 57.61B | 54.91B | 52.76B | 53.80B | Total Debt |
3.01B | 2.95B | 3.36B | 3.63B | 3.18B | 3.20B | Net Debt |
-9.74B | -10.98B | -8.97B | -8.58B | -10.35B | -9.53B | Total Liabilities |
16.50B | 15.85B | 16.03B | 15.31B | 14.24B | 17.29B | Stockholders Equity |
32.51B | 40.89B | 39.26B | 36.66B | 35.79B | 33.87B |
Cash Flow | Free Cash Flow | ||||
0.00 | 1.98B | 1.50B | -758.81M | 1.27B | 358.29M | Operating Cash Flow |
0.00 | 3.28B | 3.28B | 951.64M | 2.58B | 1.59B | Investing Cash Flow |
0.00 | -1.53B | -1.23B | -1.18B | -811.51M | -1.08B | Financing Cash Flow |
0.00 | -1.92B | -2.30B | -1.24B | -922.64M | -381.86M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | ¥10.83B | 9.28 | 4.61% | 6.57% | 32.45% | ||
74 Outperform | $129.04B | 10.65 | 6.65% | 1.34% | 5.21% | -9.31% | |
73 Outperform | ¥33.12B | 3.53 | 4.19% | 0.79% | 104.91% | ||
70 Outperform | ¥343.10B | 31.22 | 3.15% | 13.59% | 24.68% | ||
66 Neutral | ¥6.54B | 9.06 | 3.48% | 0.26% | 80.37% | ||
60 Neutral | ¥13.99B | 27.57 | 3.81% | 5.54% | -51.26% | ||
51 Neutral | $2.02B | -1.19 | -21.37% | 3.64% | 2.88% | -30.57% |